CRC patients with high NLGN1 expressions in GSE24551 had significantly decreased 5-year overall survival rates (5Y-OS) than those with low NLGN1 expression (45.2% vs. 74.8%, P = 0.0002, Fig. 5A). Here, NLGN1 is linked to colorectal carcinoma.